Apixio

AI-driven healthcare analytics platform

San Mateo, California, United States

About Apixio

Apixio focuses on healthcare analytics by using artificial intelligence and machine learning to analyze clinical documents for health plans and providers. Their platform automates coding and auditing processes, improving accuracy and efficiency compared to traditional methods. By specializing in risk adjustment, Apixio helps clients predict healthcare costs and enhance patient care. The company's goal is to unlock the potential of clinical data to improve healthcare delivery and outcomes.

San Mateo, CaliforniaHeadquarters
2009Year Founded
$35.1MTotal Funding
SERIES_DCompany Stage
AI & Machine Learning, HealthcareIndustries
201-500Employees

Benefits

Compensation - Competitive salary, 401k match, and stock options
Health insurance - Exceptional medical, dental, and vision coverage
Career development - Annual stipend for professional events and education
Health & Wellness - Annual stipend for health and wellness programs
Time off - Generous vacation policy, paid holidays, and parental leave
Grub - Catered lunches, healthy snacks, and refreshing drinks
Commuter benefits - Free parking, pre-tax transit benefits, and shuttle service
Events - Team parties, outings, employee recognition, and happy hours

Risks

Integration with existing EHR systems may face resistance from healthcare providers.
The healthcare analytics market is becoming increasingly competitive with new entrants.
Data privacy and security concerns could lead to regulatory challenges for Apixio.

Differentiation

Apixio uses AI to automate coding and auditing, improving efficiency and accuracy.
The company offers centralized patient health profiles for better data-driven insights.
Apixio's platform supports risk adjustment and payment integrity for healthcare organizations.

Upsides

AI-driven predictive analytics are gaining traction, enhancing Apixio's service offerings.
The demand for AI solutions in healthcare is projected to grow significantly by 2026.
Apixio's partnership with Vim enhances real-time insights at the point of care.

Funding

Total raised$35.12 M
Latest valuation$96.50 M
StageSERIES_D
$14
$67.50 M
SERIES A
2/28/2011
$3
$14.00 M